NCT03143166View on ClinicalTrials.gov

Pradaxa Tablet Proton Pump Inhibitor (PPI) Bioavailability (BA) Study in Japan

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

May 22, 2017

Primary Completion Date

July 27, 2017

Study Completion Date

August 2, 2017

Conditions
Non-alcoholic Fatty Liver Disease
Interventions
DRUG

Dabigatran Etexilate

Tablet, film coated

DRUG

Rabeprazol sodium

Tablet

Trial Locations (1)

812-0025

Souseikai Hakata Clinic, Fukuoka, Fukuoka

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT03143166 - Pradaxa Tablet Proton Pump Inhibitor (PPI) Bioavailability (BA) Study in Japan | Biotech Hunter | Biotech Hunter